Literature DB >> 3717375

Ventricular efficiency predicted by an analytical model.

D Burkhoff, K Sagawa.   

Abstract

Based on the recent data from the literature, we derived analytic expressions for ventricular stroke work (SW), ventricular O2 consumption, and the ratio of the former to the latter, defined as ventricular efficiency, in terms of ventricular contractile properties and arterial afterloading properties. The ventricular properties were quantified by Ees and V0, the slope and volume axis intercept, respectively, of the linear end-systolic pressure-volume relationship. Ventricular afterload was represented by the effective arterial elastance (Ea), a parameter that is dependent on aortic input impedance parameters. O2 consumption was assessed by estimating ventricular pressure-volume area, which has been shown to be linearly related to O2 consumption. Model analysis indicated that SW is maximum when Ea = Ees, the afterload that results in the greatest efficiency is always less than that which provides the maximum SW, the SW and efficiency of a weak heart are more sensitive to changes in afterload than in a strong heart, and there is a sigmoidal relation between ventricular efficiency and end-diastolic volume that reaches its maximum at volumes outside the upper limit of the physiological range. Further analysis of the model indicated that under physiological conditions ventricular and arterial properties may be adjusted more toward optimization of efficiency than SW.

Entities:  

Mesh:

Year:  1986        PMID: 3717375     DOI: 10.1152/ajpregu.1986.250.6.R1021

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  85 in total

1.  Determination of the target ventricular rate in patients with atrial fibrillation by evaluation of ventriculoarterial coupling.

Authors:  Sachihiko Nobuoka; Seiji Hatano; Junzo Nagashima; Akihiro Yoshida; Hisanobu Adachi; Yukiko Imai; Masaaki Shibamoto; Kyoko Ikeda; Fumihiko Miyake
Journal:  Tex Heart Inst J       Date:  2002

Review 2.  Ventriculo-arterial coupling: concepts, assumptions, and applications.

Authors:  D A Kass; R P Kelly
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

Review 3.  Ventriculovascular coupling in systolic and diastolic heart failure.

Authors:  Justin M Fox; Mathew S Maurer
Journal:  Curr Heart Fail Rep       Date:  2005-12

4.  Mechanical effects of liriodenine on the left ventricular-arterial coupling in Wistar rats: pressure-stroke volume analysis.

Authors:  K C Chang; M J Su; Y I Peng; C C Shao; Y C Wu; Y Z Tseng
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

5.  Ventriculovascular coupling in systolic and diastolic heart failure.

Authors:  Justin M Fox; Mathew S Maurer
Journal:  Curr Cardiol Rep       Date:  2006-05       Impact factor: 2.931

6.  Ventricular energetics in aortic root replacement for annuloaortic ectasia with aortic regurgitation.

Authors:  Yoshihisa Tanoue; Yukihiro Tomita; Shigeki Morita; Ryuji Tominaga
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

7.  The sex-specific impact of systolic hypertension and systolic blood pressure on arterial-ventricular coupling at rest and during exercise.

Authors:  Paul D Chantler; Vojtech Melenovsky; Steven P Schulman; Gary Gerstenblith; Lewis C Becker; Luigi Ferrucci; Jerome L Fleg; Edward G Lakatta; Samer S Najjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 8.  Methods for measuring right ventricular function and hemodynamic coupling with the pulmonary vasculature.

Authors:  Alessandro Bellofiore; Naomi C Chesler
Journal:  Ann Biomed Eng       Date:  2013-02-20       Impact factor: 3.934

Review 9.  How to measure pulmonary vascular and right ventricular function.

Authors:  Naomi C Chesler; Alejandro Roldan; Rebecca R Vanderpool; Robert Naeije
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

10.  Aminoguanidine prevents age-related deterioration in left ventricular-arterial coupling in Fisher 344 rats.

Authors:  Kuo-Chu Chang; Kwan-Lih Hsu; Tsai-Fwu Chou; Huey-Ming Lo; Yung-Zu Tseng
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.